-
2
-
-
0035050460
-
Diabetes, hypertension, and cardiovascular disease: an update
-
Sowers JR, Epstein M, Frohlich ED. Diabetes, hypertension, and cardiovascular disease: an update. Hypertension. 2001;37:1053-1059.
-
(2001)
Hypertension.
, vol.37
, pp. 1053-1059
-
-
Sowers, J.R.1
Epstein, M.2
Frohlich, E.D.3
-
3
-
-
81555200338
-
The role of overweight and obesity in the cardiorenal syndrome
-
Sowers J, Whaley-Connell A, Hayden M. The role of overweight and obesity in the cardiorenal syndrome. Cardiorenal Med. 2011;1:5-12.
-
(2011)
Cardiorenal Med.
, vol.1
, pp. 5-12
-
-
Sowers, J.1
Whaley-Connell, A.2
Hayden, M.3
-
4
-
-
78650980097
-
Hypertension, dyslipidemia, and insulin resistance in patients with diabetes mellitus or the cardiometabolic syndrome: benefits of vasodilating B-blockers
-
Deedwania P. Hypertension, dyslipidemia, and insulin resistance in patients with diabetes mellitus or the cardiometabolic syndrome: benefits of vasodilating B-blockers. J Clin Hypertens (Greenwich). 2011;13:52-59.
-
(2011)
J Clin Hypertens (Greenwich).
, vol.13
, pp. 52-59
-
-
Deedwania, P.1
-
5
-
-
0031860340
-
Protein kinase C activation and the development of diabetes complications
-
Koya D, King GL. Protein kinase C activation and the development of diabetes complications. Diabetes 1998;47:859-866.
-
(1998)
Diabetes
, vol.47
, pp. 859-866
-
-
Koya, D.1
King, G.L.2
-
6
-
-
0029295736
-
Advanced glycation end products promote adhesion molecule (VCAM-1, ICAM-1) expression and atheroma formation in normal rabbits
-
Vlassara H, Fuh H, Donnelly T, et al. Advanced glycation end products promote adhesion molecule (VCAM-1, ICAM-1) expression and atheroma formation in normal rabbits. Mol Med. 1995;1:447-456.
-
(1995)
Mol Med.
, vol.1
, pp. 447-456
-
-
Vlassara, H.1
Fuh, H.2
Donnelly, T.3
-
7
-
-
0032772463
-
Vascular effects of non-esterified fatty acids: implications for the cardiovascular risk factor cluster
-
Egan BM, Lu G, Green EL. Vascular effects of non-esterified fatty acids: implications for the cardiovascular risk factor cluster. Prostaglandins Leukot Essent Fatty Acids. 1999;60:411-420.
-
(1999)
Prostaglandins Leukot Essent Fatty Acids.
, vol.60
, pp. 411-420
-
-
Egan, B.M.1
Lu, G.2
Green, E.L.3
-
8
-
-
0030991505
-
Fibrinolytic function after dietary supplementation with omega3 polyunsaturated fatty acids
-
Toft I, Bonaa KH, Ingebresten OC, et al. Fibrinolytic function after dietary supplementation with omega3 polyunsaturated fatty acids. Arterioscler Thromb Vasc Biol. 1997;17:814-819.
-
(1997)
Arterioscler Thromb Vasc Biol.
, vol.17
, pp. 814-819
-
-
Toft, I.1
Bonaa, K.H.2
Ingebresten, O.C.3
-
9
-
-
35148840913
-
Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance
-
Cooper SA, Whaley-Connell A, Habibi J, et al. Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance. Am J Physiol Heart Circ Physiol. 2007;293:H2009-H2023.
-
(2007)
Am J Physiol Heart Circ Physiol.
, vol.293
-
-
Cooper, S.A.1
Whaley-Connell, A.2
Habibi, J.3
-
10
-
-
78149409465
-
Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease
-
Ren J, Pulakat L, Whaley-Connell A, et al. Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease. J Mol Med. 2010;88:993-1001.
-
(2010)
J Mol Med.
, vol.88
, pp. 993-1001
-
-
Ren, J.1
Pulakat, L.2
Whaley-Connell, A.3
-
11
-
-
77954957395
-
Angiotensin receptor blocker/diuretic combination preserves insulin responses in obese hypertensives
-
Sowers JR, Raij L, Jialal I, et al. Angiotensin receptor blocker/diuretic combination preserves insulin responses in obese hypertensives. J Hypertens. 2010;28:1761-1769.
-
(2010)
J Hypertens.
, vol.28
, pp. 1761-1769
-
-
Sowers, J.R.1
Raij, L.2
Jialal, I.3
-
12
-
-
79956188610
-
Valsartan improves beta-cell function and insulin sensitivity in subjects with impaired glucose metabolism
-
Van der Zjil NJ, Moors CC, Goossens GH, et al. Valsartan improves beta-cell function and insulin sensitivity in subjects with impaired glucose metabolism. Diabetes Care. 2011;34:845-851.
-
(2011)
Diabetes Care.
, vol.34
, pp. 845-851
-
-
Van der Zjil, N.J.1
Moors, C.C.2
Goossens, G.H.3
-
13
-
-
33845497759
-
Differences in glucose tolerance between fixed-dose antihypertensive drug combinations in people with metabolic syndrome
-
Bakris G, Molitch M, Hewkin A, et al. Differences in glucose tolerance between fixed-dose antihypertensive drug combinations in people with metabolic syndrome. Diabetes Care. 2006;29:2592-2597.
-
(2006)
Diabetes Care.
, vol.29
, pp. 2592-2597
-
-
Bakris, G.1
Molitch, M.2
Hewkin, A.3
-
14
-
-
68049124872
-
Blood pressure and glucose control in subjects with diabetes: new analyses from ADVANCE
-
Poulter NR. Blood pressure and glucose control in subjects with diabetes: new analyses from ADVANCE. J Hyperten Suppl. 2009;27:S3-S8.
-
(2009)
J Hyperten Suppl.
, vol.27
-
-
Poulter, N.R.1
-
15
-
-
42049107348
-
Telmisartan, ramipril, or both in patients at high risk of vascular events
-
ONTARGET Investigators
-
ONTARGET Investigators. Telmisartan, ramipril, or both in patients at high risk of vascular events. N Engl J Med. 2008;358:1547-1559.
-
(2008)
N Engl J Med
, vol.358
, pp. 1547-1559
-
-
-
16
-
-
67649790352
-
Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study
-
Sleight P, Redon J, Verdecchia P, et al. Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study. J Hypertens. 2009;27:1360-1369.
-
(2009)
J Hypertens.
, vol.27
, pp. 1360-1369
-
-
Sleight, P.1
Redon, J.2
Verdecchia, P.3
-
17
-
-
77951735232
-
Effects of intensive blood-pressure control in type 2 diabetes mellitus
-
The ACCORD Study Group
-
The ACCORD Study Group. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362:1575-1585.
-
(2010)
N Engl J Med
, vol.362
, pp. 1575-1585
-
-
-
18
-
-
77954374543
-
Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease
-
Cooper-DeHoff RM, Gong Y, Handberg EM, et al. Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. JAMA. 2010;304:61-68.
-
(2010)
JAMA.
, vol.304
, pp. 61-68
-
-
Cooper-DeHoff, R.M.1
Gong, Y.2
Handberg, E.M.3
-
19
-
-
0038460302
-
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and treatment of High Blood Pressure: the JCN 7 report
-
Chobanian AV, Bakris GL, Black HR. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and treatment of High Blood Pressure: the JCN 7 report. JAMA. 2003;289:2560-2571.
-
(2003)
JAMA.
, vol.289
, pp. 2560-2571
-
-
Chobanian, A.V.1
Bakris, G.L.2
Black, H.R.3
-
20
-
-
0037527647
-
2003 European Society of Hypertension-European Society of cardiology guidelines for the management of arterial hypertension
-
European Society of Hypertension-European Society of Cardiology Guidelines Committee
-
European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003; 21:1011-1054.
-
(2003)
J Hypertens
, vol.21
, pp. 1011-1054
-
-
-
21
-
-
0025831464
-
Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension in the Elderly Program
-
SHEP Cooperative Research Group
-
SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension in the Elderly Program. JAMA. 1991;265:3255-3264.
-
(1991)
JAMA
, vol.265
, pp. 3255-3264
-
-
-
22
-
-
0344373794
-
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial
-
ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group
-
ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial. JAMA. 2002;288:2981-2997.
-
(2002)
JAMA
, vol.288
, pp. 2981-2997
-
-
-
23
-
-
7744231805
-
Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial
-
Nissen SE, Tuzcu EM, Libby P, et al. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial. JAMA. 2004;292:2217-2225.
-
(2004)
JAMA
, vol.292
, pp. 2217-2225
-
-
Nissen, S.E.1
Tuzcu, E.M.2
Libby, P.3
-
24
-
-
57349138291
-
Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high risk patients
-
Jamerson K, Weber MA, Bakris GL, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high risk patients. N Engl J Med. 2008;359:2417-2428.
-
(2008)
N Engl J Med.
, vol.359
, pp. 2417-2428
-
-
Jamerson, K.1
Weber, M.A.2
Bakris, G.L.3
-
25
-
-
77953646392
-
Cardiovascular events during differing hypertension therapies in patients with diabetes
-
Weber MA, Bakris GL, Jamerson K, et al. Cardiovascular events during differing hypertension therapies in patients with diabetes. J Am Coll Cardiol. 2010;56:77-85.
-
(2010)
J Am Coll Cardiol
, vol.56
, pp. 77-85
-
-
Weber, M.A.1
Bakris, G.L.2
Jamerson, K.3
-
26
-
-
33845257120
-
Impact of blood pressure control and angiotensin-converting enzyme inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: a post hoc analysis of the BENEDICT trial
-
Ruggenenti P, Perna A, Ganeva M, et al. Impact of blood pressure control and angiotensin-converting enzyme inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: a post hoc analysis of the BENEDICT trial. J Am Soc Nephrol. 2006;17:3472-3481.
-
(2006)
J Am Soc Nephrol.
, vol.17
, pp. 3472-3481
-
-
Ruggenenti, P.1
Perna, A.2
Ganeva, M.3
-
27
-
-
79952373965
-
Olmesartan for delay or prevention of microalbuminuria in type 2 diabetes
-
Haller H, Ito S, Izzo J, et al. Olmesartan for delay or prevention of microalbuminuria in type 2 diabetes. N Engl J Med. 2011;364:907-917.
-
(2011)
N Engl J Med.
, vol.364
, pp. 907-917
-
-
Haller, H.1
Ito, S.2
Izzo, J.3
-
28
-
-
67649659279
-
Effect of candesartan on microalbuminuria and albumin excretion rate in diabetes: three randomized trials
-
Bilous R, Chatuverdi N, Sjolie AK, et al. Effect of candesartan on microalbuminuria and albumin excretion rate in diabetes: three randomized trials. Ann Intern Med. 2009;15:11-20.
-
(2009)
Ann Intern Med.
, vol.15
, pp. 11-20
-
-
Bilous, R.1
Chatuverdi, N.2
Sjolie, A.K.3
-
29
-
-
67649635807
-
Renal and retinal effects of enlapril and losartan in type 1 diabetes
-
Mauer M, Zinman B, Gardinar R, et al. Renal and retinal effects of enlapril and losartan in type 1 diabetes. N Engl J Med. 2009;361:40-51.
-
(2009)
N Engl J Med.
, vol.361
, pp. 40-51
-
-
Mauer, M.1
Zinman, B.2
Gardinar, R.3
-
30
-
-
0032513878
-
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial
-
Hansson L, Zanchette A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet. 1998;351:1755-1762.
-
(1998)
Lancet.
, vol.351
, pp. 1755-1762
-
-
Hansson, L.1
Zanchette, A.2
Carruthers, S.G.3
-
31
-
-
79953681036
-
CON: blood pressure treatment goal for patients with diabetes should be <130/80mmHg
-
Bakris G. CON: blood pressure treatment goal for patients with diabetes should be <130/80mmHg. J Clin Hypertens (Greenwich). 2011;13:263-265.
-
(2011)
J Clin Hypertens (Greenwich)
, vol.13
, pp. 263-265
-
-
Bakris, G.1
-
32
-
-
77952105361
-
ASH Position paper: treatment of hypertension in patients with diabetes-an update
-
on behalf of the American Society of Hypertension Writing Group
-
Bakris GL, Sowers JR, on behalf of the American Society of Hypertension Writing Group. ASH Position paper: treatment of hypertension in patients with diabetes-an update. J Am Soc Hyperten. 2010;4:62-67.
-
(2010)
J Am Soc Hyperten
, vol.4
, pp. 62-67
-
-
Bakris, G.L.1
Sowers, J.R.2
|